Farzin Beygui: SOLOTAVI Tests Aspirin Discontinuation After TAVI
Farzin Beygui, Professor of Cardiology at University of Caen Normandy, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in American Heart Journal, adding:
“Proud to share the publication of the SOLOTAVI randomized trial design.
The study is assessing aspirin discontinuation at 90 days versus standard long term therapy after TAVI in patients with no ‘other’ indication for aspirin.
Congratulations and many thanks to the study investigators and co-authors of the 23 french centers, for their commitment and major envolvement that has already led to the recruitment of nearly half of the expected 1400.
Looking forward to sharing the results.”
Title: Rationale for Early Discontinuation of Aspirin After Transcatheter Aortic Valve Implantation: Design of the SOLOTAVI Randomized Trial
Authors: Farzin Beygui, Christophe Caussin, Stéphanie Marlière, Guillaume Bonnet, Eric Durand, Thibaud Lhermusier, Jean-Francois Morelle, Stéphane Delépine, Géraud Souteyrand, Said Ghostine, Eric Van Belle, Olivier Barthélémy, Mariama Akodad, Guillaume Cayla, Chekrallah Chamandi, Frank Chemouni, Jean-Jacques Parienti, Claire Bouleti, Hélène Eltchaninoff
Stay updated with Hemostasis Today.
-
Nov 7, 2026, 13:50Edward Lee Carter: Is Aspirin Monotherapy Sufficient After Watchman Implantation?
-
Nov 7, 2026, 13:40Leticia Leal: Preventing Blood Clots During Long Flights
-
Nov 7, 2026, 12:06Kinza Raza: Giving Back Through Thalassaemia Awareness – A Journey Back to School
-
Nov 7, 2026, 12:03Sean Langenfeld: Rectal Bleeding on Anticoagulation – Don’t Miss Colorectal Cancer
-
Nov 7, 2026, 11:54Sade Oguntola: Modernizing African Traditional Medicine – A New Hope for SCD
-
Nov 7, 2026, 11:44José Antonio García Erce: Patient Blood Management Needs a National Strategy
-
Nov 7, 2026, 11:37Rana Al-Hrout: ITP Treatment in 2026 – Moving Beyond Platelet Counts
-
Nov 7, 2026, 09:00Charlotte Guzzo: MHRA Approves Gene Editing for Younger Children
-
Nov 7, 2026, 08:47Mohammedbaqer Ali Al-Ghuraibawi: Rethinking Aspirin Use After Acute Coronary Syndrome